EP1235607A1 — Medicament dispenser
Assigned to Glaxo Group Ltd · Expires 2002-09-04 · 24y expired
What this patent protects
There is provided a medicament dispenser comprising a body (4), a medicament carrier (80), an exit channel (70) for passage of the medicament to a patient, and access means for directly or indirectly exposing the exit channel (70) for use by the patient, wherein the access means …
USPTO Abstract
There is provided a medicament dispenser comprising a body (4), a medicament carrier (80), an exit channel (70) for passage of the medicament to a patient, and access means for directly or indirectly exposing the exit channel (70) for use by the patient, wherein the access means (70) comprises an access coupling (74). The coupling (74) is reversibly deformable in response to the application of non-mechanical energy thereto. The non-mechanical energy may comprise heat energy, electrical current energy, electrical field energy or magnetic field energy.
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.